KURA ONCOLOGY, INC. (KURA) capitalization

Current snapshot

Market Cap
$721.7M
88.8M shares × $8.13 · as of last filing 2026-03-31
Net Worth
$107.9M
Stockholders' equity · 2026-03-31
Enterprise Value
$706.9M
Market cap + debt − cash
Net Debt
-$14.8M
Debt $24.3M − Cash $39.1M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $911.0M
FY'24 2024-12-31 $750.5M
FY'23 2023-12-31 $1.05B
FY'22 2022-12-31 $831.3M
FY'21 2021-12-31 $928.9M
FY'20 2020-12-31 $1.73B
FY'19 2019-12-31 $624.0M
FY'18 2018-12-31 $535.6M
FY'17 2017-12-31 $450.2M
FY'16 2016-12-31 $114.2M
FY'15 2015-12-31 $152.4M
FY'14 2014-12-31
FY'13 2013-12-31
FY'12 2012-12-31
FY'11 2011-12-31
FY'11 2010-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $720.4M
Q4'25 2025-12-31 $912.8M
Q3'25 2025-09-30 $775.7M
Q2'25 2025-06-30 $505.4M
Q1'25 2025-03-31 $576.9M
Q4'24 2024-12-31 $681.4M
Q3'24 2024-09-30 $1.70B
Q2'24 2024-06-30 $1.78B
Q1'24 2024-03-31 $1.79B
Q4'23 2023-12-31 $1.07B
Q3'23 2023-09-30 $704.4M
Q2'23 2023-06-30 $738.4M
Q1'23 2023-03-31 $836.6M
Q4'22 2022-12-31 $847.8M
Q3'22 2022-09-30 $913.7M
Q2'22 2022-06-30 $1.22B
Q1'22 2022-03-31 $1.07B
Q4'21 2021-12-31 $932.0M
Q3'21 2021-09-30 $1.24B
Q2'21 2021-06-30 $1.38B
Q1'21 2021-03-31 $1.87B
Q4'20 2020-12-31 $2.16B
Q3'20 2020-09-30 $1.74B
Q2'20 2020-06-30 $916.3M
Q1'20 2020-03-31 $452.0M
Q4'19 2019-12-31 $624.0M
Q3'19 2019-09-30 $687.2M
Q2'19 2019-06-30 $889.8M
Q1'19 2019-03-31 $633.2M
Q4'18 2018-12-31 $535.6M
Q3'18 2018-09-30 $665.2M
Q2'18 2018-06-30 $603.7M
Q1'18 2018-03-31 $616.0M
Q4'17 2017-12-31 $450.2M
Q3'17 2017-09-30 $435.4M
Q2'17 2017-06-30 $185.9M
Q1'17 2017-03-31 $173.1M
Q4'16 2016-12-31 $114.2M
Q3'16 2016-09-30 $119.0M
Q2'16 2016-06-30 $50.8M
Q1'16 2016-03-31 $74.7M
Q4'15 2015-12-31 $152.4M
Q3'15 2015-09-30 $153.1M
Q2'15 2015-06-30
Q1'15 2015-03-31
Q4'14 2014-12-31
Q3'14 2014-09-30
Q2'14 2014-06-30
Q1'14 2014-03-31
Q4'13 2013-12-31
Q3'13 2013-09-30
Q2'13 2013-06-30
Q1'13 2013-03-31
Q4'12 2012-12-31
Q3'12 2012-09-30
Q2'12 2012-06-30
Q1'12 2012-03-31
Q4'11 2011-12-31
Q3'11 2011-09-30
Q2'11 2011-06-30
Q1'12 2011-03-31
Q4'11 2010-12-31
Q3'11 2010-09-30
Q2'11 2010-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (KURA CIK 0001422143), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

CLW

CLEARWATER PAPER CORPORATION

LNTH

LANTHEUS HOLDINGS, INC.

TBPH

THERAVANCE BIOPHARMA, INC.